Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma.
Taniguchi SH, Komine K, Takenaga N, Yoshida Y, Sasaki K, Kawamura Y, Kasahara Y, Ouchi K, Imai H, Saijo K, Shirota H, Takahashi M, Ishioka C. Taniguchi SH, et al. Among authors: ishioka c. Anticancer Res. 2023 Dec;43(12):5699-5704. doi: 10.21873/anticanres.16775. Anticancer Res. 2023. PMID: 38030182
Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation.
Yoshioka T, Sakayori M, Kato S, Chiba N, Miyazaki S, Nemoto K, Shibata H, Shimodaira H, Ohtsuka K, Kakudo Y, Sakata Y, Ishioka C. Yoshioka T, et al. Among authors: ishioka c. Int J Clin Oncol. 2006 Dec;11(6):454-60. doi: 10.1007/s10147-006-0610-5. Epub 2006 Dec 25. Int J Clin Oncol. 2006. PMID: 17180514
[Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
Kato S, Yasuda K, Nishino Y, Ohori H, Takahashi M, Takahashi S, Yamaura G, Ohtsuka K, Kakudo Y, Chiba N, Shimodaira H, Sakayori M, Kato S, Suzuki T, Murakawa Y, Gamoh M, Shibata H, Yoshioka T, Ishioka C. Kato S, et al. Among authors: ishioka c. Gan To Kagaku Ryoho. 2007 Aug;34(8):1227-31. Gan To Kagaku Ryoho. 2007. PMID: 17687203 Japanese.
Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes.
Ishida T, Kiba T, Takeda M, Matsuyama K, Teramukai S, Ishiwata R, Masuda N, Takatsuka Y, Noguchi S, Ishioka C, Fukushima M, Ohuchi N. Ishida T, et al. Among authors: ishioka c. Cancer Chemother Pharmacol. 2009 Jul;64(2):361-9. doi: 10.1007/s00280-008-0882-8. Epub 2008 Dec 12. Cancer Chemother Pharmacol. 2009. PMID: 19082596 Free PMC article. Clinical Trial.
291 results